Just to add, I don't know if any of you received the Letter from the California Society of Pathologists, but the Anthem cuts are coming, and they are massive. Will definitely hit the bottom line.
Here are some examples of the rate changes, to give you an idea of their scale and scope across key CPT codes that are the "bread and butter" of pathology: |
See below for a message from the President of CSP.
February 20, 2020
Dear Colleague,
A few weeks ago, I wrote to you about dramatic cuts in reimbursement to pathologists recently imposed by Anthem-Blue Cross. A copy of that letter is
available here. I promised to follow-up with more information about the cuts, and what they may mean to you, as well as what the CSP plans to do to fight this threat to your future income and independence as a pathologist.
To summarize the nature of the threat we are facing, consider the following:
- The reductions in payment for many common anatomic pathology procedures, like CPT codes 88305, 88307, 88341, 88342, and 87480, are to levels substantially below the Medicare fee schedule and in many cases, less even than Medi-Cal.
- These cuts were imposed unilaterally, without negotiation, or even, in some cases, notification.
- The greatest impact now is on independent pathology groups operating their own anatomic pathology labs, who have no protection if they are out of network. Thanks to California state law AB72 (which the CSP helped pass), a hospital-based group that is out of network with Anthem or any other plan, would be protected and paid at the greater of: plan average contracted rate or; 125% of Medicare.
- These new Anthem rates are in many cases below cost, and will make many independent pathology practices unsustainable.
- Right now, the damage is limited to those independent pathology practices that have a substantial book of business through Anthem.
- If this does not apply to you, you should still be worried – here is why:
- If these Anthem rates are allowed to stand, it is likely other insurers will notice, and it could trigger a “race to the bottom” in payment for pathology professional services.
- Accepting rates below Medi-Cal exposes pathologists to the “most favored nations” clause in state law that entitles Medi-Cal to the lowest rate a provider accepts, resulting in a drop in Medi-Cal payments too – a double hit!
- If you are a salaried physician at an academic center, large medical group, public hospital or in another setting, you are also at risk, because your compensation is ultimately also tied to that of community pathologists – to paraphrase, a “dropping tide lowers all boats.”
What can the CSP do on your behalf?
Our goal is to fix AB 72, the California Out of Network billing statute, so the law also establishes a floor in reimbursement for out of network independent labs, similar to the protections provided in AB 72 for hospital-based pathology groups. An effort like this requires resources to:
- Secure a legal analysis of options available to challenge the magnitude of the cuts implemented;
- Mount an advocacy effort to sponsor a bill to expand the protections of AB 72 to out of network pathology labs;
- Work with other medical specialties, the CA Medical Assoc. and CA Hospital Association to gain support for the needed changes;
- Retain a Public Relations firm to hone our message and arguments, outreach to publications to highlight the impact of payer actions like this, and how fixing AB72 can help;
- Conduct a grassroots campaign to coordinate outreach in writing and in person with members of key Legislative Committees.
The CSP Board has created a Pathology Defense Fund to provide the resources needed for this effort - this is an extraordinary threat, which cannot be addressed through your Society’s normal operating budget.
What can you do?
We are asking each pathologist (or their group) to contribute $1,000 per pathologist to the Pathology Defense Fund. This represents a significant commitment, but if you consider the potential impact of these new rates on your practice, we think you will agree that the time to act is now.